Baidu
map

8月31日全球新冠肺炎(COVID-19)疫情简报,确诊超2537万,墨西哥死亡率超10%

2020-08-31 MedSci原创 MedSci原创

Worldometers世界实时统计数据显示,截至北京时间8月31日7时22分,全球新冠肺炎(COVID-19)累计确诊病例突破2537万例,达到25,376,526例,累计死亡病例超过85万例,达到

Worldometers世界实时统计数据显示,截至北京时间8月31日7时22分,全球新冠肺炎COVID-19)累计确诊病例突破2537万例,达到25,376,526例,累计死亡病例超过85万例,达到850,140例,康复为17,698,027例。美国新冠肺炎累计确诊病例全球最多,超617万例,达到6,172,079例,累计死亡病例超过18.7万例,达到187,215例,不过昨日新增死亡仅360例,较此前每日1000例大大下降。昨日报道:8月30日全球新冠肺炎(COVID-19)疫情简报,确诊超2514万,新冠病毒深刻改变人类教育方式及精神状况

全球疫情持续蔓延,美洲地区,美国已有多所高校出现校园疫情,巴西将于当地时间下周二正式宣布延长一项疫情紧急救助计划;欧洲地区,疫情复燃趋势仍在不断加剧,法国新冠病毒传播“呈指数增长”;非洲地区,疫情对南非社会经济产生巨大影响;亚洲地区,印度连续32天日增超5万例,韩国对首都圈部分感染风险较高的场所实施“加强版”防疫指针。

墨西哥的新冠肺炎的死亡率最高,超10%

在全球,墨西哥的死亡率最高,超10%,目前确诊为591,712例,死亡为63,819例,昨日新增5,974例,死亡673例。可能与大量新冠肺炎病例未确诊,以及当地医疗条件欠佳等因素有关。

秘鲁人均死亡率第一

秘鲁媒体报道称,自3月19日该国报告首例因新冠病毒死亡病例至今,平均每天新增176例死亡病例,即每小时有至少7人因感染新冠病毒离世 。同时,基于国家统计和信息机构全国人口数据计算,该国每10万人中有超过85.8人因感染新冠病毒而离世,也因此成为全球人均新冠病毒死亡率最高的国家。

秘鲁国家统计局日前发布的数据显示,受新冠肺炎疫情影响,今年上半年,该国经济同比萎缩达17.37%,广告业也因此成为该国受冲击最大的行业之一。

美国多所大学出现严重疫情

根据Worldometer实时统计数据,截至北京时间8月31日6时30分左右,美国累计确诊新冠肺炎病例6169860例,累计死亡187194例。与前一日6时30分数据相比,美国新增确诊病例34492例,新增死亡病例410例。

美国校园疫情正持续蔓延。位于美国得克萨斯州沃斯堡的得克萨斯基督教大学报告称,其教职员工及在校学生中已确诊447例新冠肺炎。该校学生事务负责人表示,目前在校园内外大型聚会时有发生,这可能是新冠病毒迅速传播的主要原因。

美国南加州大学8月24日宣布,由于住在校外宿舍的学生中暴发新冠疫情,该校有100多名学生被隔离14天。美国圣母大学则在上个周末新增50例新冠确诊病例。而在上周,美国北卡罗来纳大学教堂山分校已把本科课程转为线上授课,原因在于开学短短一周内,该校竟发生了四起聚集性感染事件。目前,美国已有多所高校出现校园疫情,不少大学被迫恢复线上授课。

巴西疫情紧急救助计划将延期至年底

据巴西卫生部当地时间8月30日晚公布的最新数据,该国单日新增新冠肺炎确诊病例16158例,累计确诊3862311例;新增死亡病例366例,累计死亡病例120828例。目前,巴西确诊病例和死亡病例仍居全球第二,仅次于美国。

巴西政府官员周六(北京时间29日)表示,巴西将于当地时间下周二正式宣布延长一项疫情紧急救助计划。这项计划旨在帮助巴西民众在疫情期间抵御经济损失。目前尚不知晓未来援助款的价值,但政府高层已经表示,发放给低收入人群的补贴金额将少于目前每人每月600巴西雷亚尔(约合111美元)的水平。

欧洲:多国新冠疫情复燃趋势加剧 法国称病毒传播“呈指数增长”

截至北京时间8月31日6时30分左右,Worldometer网站实时统计数据显示:欧洲地区48个国家报告了新冠肺炎确诊病例3554878例,死亡207384例。数据显示,欧洲累计确诊病例数最多的三个国家依次为俄罗斯、西班牙和英国。

近来,欧洲多国的新冠疫情复燃趋势仍在不断加剧,英国、法国等欧洲主要国家的单日新增确诊病例纷纷创下新高。目前这波欧洲疫情当中,以年轻人感染居多。欧洲多国政府已开始重新收紧防疫政策,对卷土重来的疫情严阵以待。

法国卫生部回顾过去一周疫情,说法国新冠病毒传播“呈指数增长”。法国是欧洲疫情最严重国家之一,法卫生部门说,病毒目前主要在年轻人之间传播,他们不易出现严重症状。美联社报道称,法国人夏季在国内旅行,举办家庭聚会和舞会可能是推高确诊病例数的原因。

德国总理默克尔日前表示,目前看来,新冠疫情在今年秋冬两季仍将持续,届时的关键问题在于如何在人们长时间待在室内的情况下使新增病例数维持在低位。默克尔提醒公众,必须预见到今后数月许多方面将比夏季更加艰难。她强调,尽管进行了大量研究,但仍未有针对新冠病毒的特效药或疫苗问世,考虑到过去数周德国新增确诊人数显著反弹,她的基本态度是人们应“保持警惕、认真防疫”。

俄联邦消费者权益保护和公益监督局表示,在日前完成的检测中,24%至26%的被检测者带有新冠病毒抗体。总统新闻秘书佩斯科夫28日表示,在克里姆林宫工作的人员不会被强制要求接种新冠疫苗。卫生部部长穆拉什科同日说,今年不会为俄儿童接种新冠疫苗。

非洲:疫情对南非社会经济产生巨大影响 尼日利亚“震中”度过疫情高峰

截至北京时间8月31日6时30分左右,Worldometer网站实时统计数据显示:非洲地区57个国家报告了新冠肺炎确诊病例1250169例,死亡29631例。确诊病例数前三的国家分别是南非、埃及、尼日利亚。

联合国开发计划署最新研究显示,新冠肺炎疫情对南非社会经济产生巨大影响。南非的整体GDP预计将在2020年最低下降5.1%,最高下降7.9%,2024年之前将缓慢恢复。南非有54%的家庭会失去正式工作,只能通过打散工为生,这导致很多中产阶级变成贫困阶层。开发计划署预计会有34%的家庭从中产阶级变成贫困阶层。

埃及官方统计机构近期公布的报告显示,埃及2020年第二季度失业率从第一季度的7.7%上升至9.6%,疫情对埃及经济和就业形势的打击越来越明显。

尼日利亚应对疫情总统特别工作组主席穆斯塔法对外称,该国疫情“震中”拉各斯每日新增病例正逐渐减少,已度过疫情高峰,在过去的几天该国高原州新增病例已超过拉各斯。

印度再现单日最大增幅

据印度卫生部30日公布的最新数据,印度新冠肺炎确诊病例升至3542734例。在过去24小时内,印度新增确诊病例78761例,为单日最大增幅,连续32天日增超5万例。新增死亡病例948例,累计死亡63498例。

印度媒体29日报道称,该国已有超8.7万名医护人员感染新冠病毒,其中573名医护人员病亡。印度公共卫生专家担心这将对印度的抗疫努力带来不利影响。另据印度南部泰米尔纳德邦首府金奈的米高梅医疗中心29日发布的消息,该院日前对一名新冠肺炎患者成功实施了双肺移植手术。

日本

据NHK电视台报道,截至当地时间30日19时,日本报告新增600例新冠肺炎确诊病例,累计确诊68088万例(加上“钻石公主”号确诊病例共68800例),新增死亡病例13例,累计死亡1285例。

东京30日新增148例,时隔5天降至200人以下。新增感染病例中,二十至三十岁年轻人占了大半数,年轻一代确诊趋势明显。

韩国新增新冠肺炎确诊病例299例

韩国中央防疫对策本部30日通报,29日零时至30日零时,韩国新增新冠肺炎确诊病例299例,其中283例为本土传播病例,16例为境外输入病例,累计确诊病例升至19699例。此外,新增死亡病例两例,累计死亡323例。

鉴于当前首都圈防疫形势依然严峻,韩国政府从30日开始,在维持“保持社交距离”二级应急响应的同时,对首都圈部分感染风险较高的场所实施“加强版”防疫指针。具体包括连锁咖啡店禁止堂食;餐厅、糕点店等晚9时后禁止堂食;室内体育场馆暂停营业;补习班暂停面对面授课等。

新冠病毒二次感染后病情严重

当地时间27日,美国内华达州州立大学和州公共卫生实验室联合发表的研究报告显示,这名患者居住在内华达州里诺市,3月25日出现喉咙痛、咳嗽等轻微症状,新冠病毒检测结果呈阳性。4月27日,该患者康复,且两次新冠病毒检测结果均呈阴性。5月28日,这名男子再次感到不适。6月5日,他因呼吸急促住院,新冠病毒检测结果再次呈阳性。报告显示,该患者二次感染的病情更加严重。

此前,香港、荷兰、比利时、厄瓜多尔等地都发现二次感染病例。香港24日宣布确诊全球首例二次感染新冠肺炎病例。荷兰也发现4例类似病例,二次感染病例均为60岁以上的老年人。这些二次感染病例的共同特点是,症状都比较轻微。相比之下,美国这名患者在二次感染后病情较严重,需要住院和接受吸氧等治疗。

内华达州州立大学里诺医学院和州公卫实验室的研究人员称,病毒基因测序结果显示,该男子两次感染的新冠病毒株有差别,表明他是二次感染。至于他是如何再次受感染,目前还不清楚。内华达州公卫实验室主任、研究报告撰写人之一潘多里说,二次感染的病例对美国是潜在警讯,因为康复者除了可能再度感染,病情的严重性也难以估计。他强调说,人类对于新冠病毒仍有许多未知,“我们仍不知道病患康复后体内的免疫力有多强,能维持多久,或抗体对于避免二次感染可发挥多大的作用。”

内容来自于人民日报,海外网,新华社,梅斯医学等

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2021-06-28 drj2003
  2. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-10-07 墙外行人

    病毒是未来医学要攻克的一大难题呀

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-09-01 14818eb4m67暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 120a3a93m72(暂无昵称)

    形式仍然严峻

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 120a3a93m72(暂无昵称)

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 ms1000002070729749

    控制疫情,刻不容缓

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 146e4e40m72暂无昵称

    感谢分享

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 温柔一点

    学习了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1941085, encodeId=60e8194108596, content=<a href='/topic/show?id=e79c423459f' target=_blank style='color:#2F92EE;'>#墨西哥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42345, encryptionId=e79c423459f, topicName=墨西哥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Mon Jun 28 20:31:31 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890452, encodeId=af278904521f, content=病毒是未来医学要攻克的一大难题呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6fMT0Okb9r7vt1jG2JQzeEqvoHDMzPjibsJwKGqJ94SXaIpDENZtZ1Gqd3rLEoEAJe4QF32JrhCAw7koInLdUCw/132, createdBy=9e3f5330676, createdName=墙外行人, createdTime=Wed Oct 07 05:22:38 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881629, encodeId=ed0f8816291d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Tue Sep 01 08:05:09 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881323, encodeId=2fb688132361, content=形式仍然严峻, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:51 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881322, encodeId=fddd88132203, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81e62195995, createdName=120a3a93m72(暂无昵称), createdTime=Mon Aug 31 12:57:20 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028489, encodeId=d12c1028489a5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Aug 31 10:31:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881287, encodeId=f5dc88128e7f, content=控制疫情,刻不容缓, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3685402411, createdName=ms1000002070729749, createdTime=Mon Aug 31 10:10:09 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881280, encodeId=2427881280cd, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Mon Aug 31 09:43:31 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881275, encodeId=8b218812e536, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIcRxbCTJVpnIS3Qlaov0s8vSHvzic4VicFDy0icdKZG4lWCQhxeCUCqenSIibYxInkgBEpAj8ObLfF1Q/132, createdBy=78cf2139876, createdName=温柔一点, createdTime=Mon Aug 31 09:31:38 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881271, encodeId=c9db8812e1b7, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 31 09:13:00 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 刘煜

    阅读谢谢分享

    0

相关资讯

8月27日全球新冠肺炎(COVID-19)疫情简报,确诊超2428万,疫苗分配与公平成为关键

据Worldometers实时统计数据显示,截至北京时间8月27日05时52分,全球新冠肺炎(COVID-19)确诊病例达2428万例,新增233,352例至24,284,622例,死亡病例达82万例

8月29日全球新冠肺炎(COVID-19)疫情简报,确诊超2488万,二次感染可能很普遍

据Worldometers实时统计数据显示,截至北京时间8月29日07时42分,全球新冠肺炎(COVID-19)确诊病例达2488万例,新增273,439例至24,888,014例,死亡病例达84万例

BMJ:英国儿童及青少年新冠肺炎患者特征

儿童及青少年中重症新冠肺炎患者比例较低,但部分患儿会出现多系统炎症综合征症状,具有与一般患儿不同的人口学和临床特征

8月30日全球新冠肺炎(COVID-19)疫情简报,确诊超2514万,新冠病毒深刻改变人类教育方式及精神状况

据Worldometers实时统计数据显示,截至北京时间8月30日07时24分,全球新冠肺炎(COVID-19)确诊病例达2514万例,新增242,726例至25,142,321例,死亡病例达84万例

8月28日全球新冠肺炎(COVID-19)疫情简报,确诊超2460万,美国制裁俄新冠病毒疫苗研发机构

据Worldometers实时统计数据显示,截至北京时间8月28日08时08分,全球新冠肺炎(COVID-19)确诊病例达2460万例,新增261,675例至24,604,235例,死亡病例达83万例

JAMA:瑞德西韦似乎对中度新冠肺炎没有明显治疗效果

近期《美国医学会杂志》(JAMA)的一份研究指出,瑞德西韦似乎对中度新冠肺炎患者没有明显治疗效果,与此前对瑞德西韦的报告结果不一致。

Baidu
map
Baidu
map
Baidu
map